Read my op-ed in @thehill on why the fight to protect Medicare Negotiation isn't over & why Congress mustn't give in to Pharma @P4AD_ thehill.com/opinion/congress…

Join us this afternoon!

One in three Americans struggles with high medication costs due to the pharmaceutical industry's practices. Learn more from @MerithBasey @P4AD_ youtube.com/watch?v=L6xAoVV4…

.@P4AD_ CEO @MerithBasey just published in @thehill - and if you care about Medicare negotiation, read it. After SCOTUS shut the door on pharma's legal challenge, Merith breaks down why the fight isn't over & what Congress is being asked to do next. thehill.com/opinion/congress…

Big Pharma Sued to Block Lower Drug Prices? Here's Why They Lost #CareTalk live @MerithBasey @P4AD_ explores w/ me @healthcarevoice @mswmediapods & @LouiseNorris @hio_org Diane-Just Care answer your health insurance questions. youtube.com/live/L6xAoVV4L6M

Listen in NOW!

It's time we rein in Big Pharma's abuse of the patent system. That’s why my colleagues should join my bill with @SenAmyKlobuchar and @SenHawleyPress so we can get more affordable generics on the market and save patients money at the pharmacy counter.

They arrived! Excited to dig in with the @P4ADNOW team! Drugs don't work if people can't afford them.

NEW VIDEO: We just released a new video explaining one of the most important — and least talked about — drivers of high drug prices: patent abuse. The ETHIC Act would close the loopholes drug companies exploit to block cheaper generics. Watch, share, and urge Congress to act: tinyurl.com/e3kr3vv2

SCOTUS declined to hear Big Pharma's petitions on Medicare Negotiation. A win for patients & the popular program that most Americans agree should be expanded on @P4AD_ @SSWorks @Public_Citizen

Si quieres tener la oportunidad de viajar a Washington D.C. para compartir tu historia con los altos precios de los medicamentos recetados, únete a la comunidad de P4AD. Es importante que tus legisladores escuchen tu historia. Comparte tu historia hoy: actionnetwork.org/forms/base…

American voters are calling for reforms to drug pricing systems and laws that have been weakened by decades of corporate greed. 📑i-mak.org/2026/02/18/voters-…

Big Pharma's abuse of the patent system to keep their profits high has limited patient access to lifesaving prescription drugs for decades but the bipartisan Eliminating Thickets to Improve Competition (ETHIC) Act could change that. The ETHIC Act addresses double patenting giving patients faster access to more affordable prescription drug options. Under this bill, a generic manufacturer would only need to successfully challenge one key patent on a brand-name drug to invalidate duplicative patents. That means the low-value patents Big Pharma has relied on to block competition and keep prices artificially high would be significantly easier to defeat. Big Pharma’s army of lobbyists is working to stop common-sense reforms like the ETHIC Act. Make sure they don’t get their way -- send a letter to your representative urging them to support ETHIC today: tinyurl.com/3bynbf37

ICYMI - New reporting on the latest Rx Price Watch analysis from @AARP shows brand-name drug prices declined 1.4% in 2024 – the first overall drop in the report’s 20-year history – aarp.org/press/releases/2026…

🗣️ P4AD patient advocates like Emily know the powerful impact of sharing their struggles with high drug costs with lawmakers firsthand. Have you been affected by high drug prices? Get involved with advocacy by sharing your story today: actionnetwork.org/forms/base…

Excellent article from Thomas Krause. A linear, logical explanation of a simple truth: creating patent thickets is standard practice and patients pay the price.

💯 P4AD advocate Marge is right. Big Pharma patient abuse isn't just bad for competition, it's bad for patients and their families. Learn how P4AD advocates are fighting back at PatientsPushForCompetition.o…

Only in the US would a successful actor be forced 2 leave his family in crippling medical debt as a result of exorbitantly priced cancer meds that sadly failed. A cruel reminder of what is at stake when Big Pharma sets and raises prices on medicines at the expense of patients.

47% of American consumers are worried about their ability to afford health insurance, care, and necessary drugs this year. @aewright, @MerithBasey, @nealemahoney, via @AmCommMedia

We’re jumping on the 2016 trend! In 2016 (and well before), @MerithBasey was part of the fight for lower drug costs. Two decades ago, she was working with children and young people living with type 1 diabetes in Latin America, where she saw what happens when life-saving medicine is priced out of reach. Now in 2026, as our CEO, Merith continues to challenge pharmaceutical industry power, dismantle unjust barriers to access, and advance a system where medicines serve people, not just markets.